Obesity Trial, Recruiting (NCT06367296)

Obesity Trial, Recruiting NCT06367296 Sponsor: Universidad de La Frontera Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT06367296 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women between 60 and 79 years old who live independently in the community (not in a nursing home or similar care facility)
People with either a normal body weight range (BMI 18.5–24.9 and body fat below 25.9%) or obesity (BMI 30–39.9 and body fat above 32%)
People who have the mental ability to understand and follow spoken instructions

Who may not be able to join:

People with nerve, muscle, or movement conditions that would make resistance (strength) training unsafe, such as severe arthritis, muscle stiffness or spasms, neurological conditions, or paralysis
People currently taking certain nutritional supplements that can affect muscle, including leucine, glutamine, casein, whey protein, fatty acids, or creatine
People with chronic (long-term) health conditions that are not being treated or are not well managed
People who have taken part in a structured resistance or strength training program within the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: GABRIEL MARZUCA, Msc, PhD, Universidad de La Frontera. Temuco, Chile

Phone: 998595445

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06367296

Sponsor: Universidad de La Frontera

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 998595445

More information: https://clinicaltrials.gov/study/NCT06367296

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women between 60 and 79 years old who live independently in the community (not in a nursing home or similar care facility)
People with either a normal body weight range (BMI 18.5–24.9 and body fat below 25.9%) or obesity (BMI 30–39.9 and body fat above 32%)
People who have the mental ability to understand and follow spoken instructions

Who may not be able to join:

People with nerve, muscle, or movement conditions that would make resistance (strength) training unsafe, such as severe arthritis, muscle stiffness or spasms, neurological conditions, or paralysis
People currently taking certain nutritional supplements that can affect muscle, including leucine, glutamine, casein, whey protein, fatty acids, or creatine
People with chronic (long-term) health conditions that are not being treated or are not well managed
People who have taken part in a structured resistance or strength training program within the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Universidad de La Frontera

Registry

ClinicalTrials.gov

Start date

1 July 2024

Est. completion

28 January 2025

Where this trial is recruiting

🇨🇱 Chile

Primary endpoints

Change in intermuscular adipose tissue (measured via ultrasonography) after prolonged resistance-type exercise training

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov